InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by COUGHLIN TIMOTHY, Director. Officer active across 2 companies, notably Travere Therapeutics, Inc.. In total, 7 filings have been logged. Total volume traded: €31k. The latest transaction was disclosed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
08,650 shares0
Common Stock
SEC:0001209191-22-036343:0·
€30,5311,439 shares@ €21.21650.015% mcap100.0% of flow
Common Stock
SEC:0001209191-22-034541:0·
03,000 shares0
Common Stock
SEC:0001209191-22-028690:0·
02,681 shares0
Common Stock
SEC:0000899243-21-022090·
02,681 shares0
Common Stock
SEC:0000899243-21-022090:0·
03,000 shares0
Common Stock
SEC:0001209191-21-033855·
03,000 shares0
Common Stock
SEC:0001209191-21-033855:0·
7 of 7 declarations
About COUGHLIN TIMOTHY
Timothy Coughlin is a Director at Travere Therapeutics, Inc. and FATE THERAPEUTICS INC. He brings his expertise to the boards, contributing to strategic decision-making for these companies. His role is essential in guiding Travere Therapeutics, Inc. and FATE THERAPEUTICS INC. in their growth initiatives.
